{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:29:09Z","timestamp":1780471749332,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cirug\u00eda Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cireng.2025.800199","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T16:24:08Z","timestamp":1756398248000},"page":"800199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunomarkers could predict overall survival and disease-free survival after neoadjuvant therapy and surgery due to locally advanced rectal cancer"],"prefix":"10.1016","volume":"103","author":[{"given":"Miguel A.","family":"Bonilla-Cozar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabel","family":"Garcia-Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"Garcia-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Luisa","family":"Reyes-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ramallo-Solis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"De la Portilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Padillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Jimenez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cireng.2025.800199_bib0005","unstructured":"Survival Rates for Colorectal Cancer. Atlanta, Georgia: American Cancer Society. https:\/\/www.cancer.org\/cancer\/colon-rectal-cancer\/detection-diagnosis-staging\/survival-rates.html [Accessed 4 November 2024]."},{"key":"10.1016\/j.cireng.2025.800199_bib0010","unstructured":"GLOBOCAN 2022. Lyon, France: International Agency for Research on Cancer 2024. https:\/\/www.iarc.who.int [Accessed 4 November 2024]."},{"key":"10.1016\/j.cireng.2025.800199_bib0015","series-title":"Estimaciones de la incidencia del c\u00e1ncer en Espa\u00f1a","year":"2024"},{"issue":"8","key":"10.1016\/j.cireng.2025.800199_bib0020","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.7150\/ijbs.15438","article-title":"A review of neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"12","author":"Li","year":"2016","journal-title":"Int J Biol Sci."},{"issue":"11","key":"10.1016\/j.cireng.2025.800199_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16112093","article-title":"Total neoadjuvant therapy for rectal cancer: which regimens to use?","volume":"16","author":"Ochiai","year":"2024","journal-title":"Cancers (Basel)."},{"issue":"17_suppl","key":"10.1016\/j.cireng.2025.800199_bib0030","doi-asserted-by":"crossref","first-page":"LBA3511","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA3511","article-title":"Total neoadjuvant treatment with long-course radiotherapy versus concurrent chemoradiotherapy in local advanced rectal cancer with high risk factors (TNTCRT): a multicenter, randomized, open-label, phase 3 trial","volume":"42","author":"Wang","year":"2024","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.cireng.2025.800199_bib0035","unstructured":"Ortiz-Hurtado H. Gu\u00edas Cl\u00ednicas de la Asociaci\u00f3n Espa\u00f1ola de Cirujanos: Cirug\u00eda Colorrectal. 2\u00baed. Madrid, Espa\u00f1a: Asociaci\u00f3n Espa\u00f1ola de Cirujanos. https:\/\/extranet.aecirujanos.es\/files\/documentacion\/documentos\/cirugia-colorrectal-2-edic.pdf [Accessed 4 November 2024]."},{"issue":"4","key":"10.1016\/j.cireng.2025.800199_bib0040","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/SLA.0000000000006161","article-title":"Surgical outcomes in total neoadjuvant therapy for rectal cancer versus standard long-course chemoradiation a systematic review and meta-analysis of randomized controlled trials","volume":"279","author":"Lin","year":"2024","journal-title":"Ann Surg."},{"issue":"24","key":"10.1016\/j.cireng.2025.800199_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15245853","article-title":"The predictors of complete pathologic response in rectal cancer during the total neoadjuvant therapy era: a systematic review","volume":"15","author":"Flom","year":"2023","journal-title":"Cancers (Basel)."},{"issue":"1","key":"10.1016\/j.cireng.2025.800199_bib0050","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/curroncol30010081","article-title":"Analysis of survival in complete pathological response after long-course chemoradiotherapy in patients with advanced rectal cancer","volume":"30","author":"Ulusoy","year":"2023","journal-title":"Curr Oncol."},{"issue":"1","key":"10.1016\/j.cireng.2025.800199_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00384-023-04589-1","article-title":"Downstaging after preoperative chemoradiation for locally advanced rectal cancer is associated with better survival than pathologic stage 0\u20131 disease treated with upfront surgery","volume":"39","author":"Kasheri","year":"2024","journal-title":"Int J Colorectal Dis."},{"issue":"1","key":"10.1016\/j.cireng.2025.800199_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40644-023-00589-0","article-title":"MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison","volume":"23","author":"Zhang","year":"2023","journal-title":"Cancer Imaging"},{"issue":"2","key":"10.1016\/j.cireng.2025.800199_bib0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/annonc\/mdj041","article-title":"Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study","volume":"17","author":"De Paoli","year":"2006","journal-title":"Ann Oncol."},{"issue":"9","key":"10.1016\/j.cireng.2025.800199_bib0070","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.cireng.2025.800199_bib0075","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.cireng.2025.800199_bib0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity."},{"issue":"10","key":"10.1016\/j.cireng.2025.800199_bib0085","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.190.10.1367","article-title":"At the crossroads of inflammation and tumorigenesis","volume":"190","author":"Cordon-Cardo","year":"1999","journal-title":"J Exp Med."},{"issue":"2","key":"10.1016\/j.cireng.2025.800199_bib0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jcp.10014","article-title":"Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis","volume":"189","author":"Shamamian","year":"2001","journal-title":"J Cell Physiol."},{"issue":"2","key":"10.1016\/j.cireng.2025.800199_bib0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3393\/ac.2021.01004.0143","article-title":"Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer","volume":"38","author":"An","year":"2022","journal-title":"Ann Coloproctol."},{"issue":"4","key":"10.1016\/j.cireng.2025.800199_bib0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for Reporting Observational Studies","volume":"61","author":"Von Elm","year":"2008","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.cireng.2025.800199_bib0105","unstructured":"Protocols and guidelines. College of American Pathologists. https:\/\/www.cap.org\/protocols-and-guidelines [Accessed 4 November 2024]."},{"issue":"5","key":"10.1016\/j.cireng.2025.800199_bib0110","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1002\/onco.13707","article-title":"College of American pathologists tumor regression grading system for long-term outcome in patients with locally advanced rectal cancer","volume":"26","author":"Chen","year":"2021","journal-title":"Oncologist."},{"key":"10.1016\/j.cireng.2025.800199_bib0115","unstructured":"Living as a Colorectal Cancer Survivor. Atlanta, Georgia: American Cancer Society. https:\/\/www.cancer.org\/cancer\/types\/colon-rectal-cancer\/after-treatment\/living.html [Accessed 4 November 2024]."},{"issue":"2","key":"10.1016\/j.cireng.2025.800199_bib0120","doi-asserted-by":"crossref","first-page":"863","DOI":"10.21873\/invivo.11850","article-title":"The role of neutrophil-to-lymphocyte ratio on the effect of CRT for patients with rectal cancer","volume":"34","author":"Ishikawa","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.cireng.2025.800199_bib0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jss.2019.07.072","article-title":"Prognostic impact of the neutrophil-to-lymphocyte ratio in stage I-II rectal cancer patients","volume":"245","author":"Yoshida","year":"2020","journal-title":"J Surg Res."},{"key":"10.1016\/j.cireng.2025.800199_bib0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2482-14-94","article-title":"Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Surg."},{"key":"10.1016\/j.cireng.2025.800199_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2021.101556","article-title":"Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: a sysyematic review and meta-analysis","volume":"37","author":"Hamid","year":"2021","journal-title":"Surg Oncol."},{"issue":"3","key":"10.1016\/j.cireng.2025.800199_bib0140","first-page":"1436","article-title":"Neutrophil-to-lymphocyte ratio: a hidden gem in predicting neoadjuvant treatment response in locally advanced rectal cancer?","volume":"25","author":"Andras","year":"2020","journal-title":"J BUON"},{"issue":"3","key":"10.1016\/j.cireng.2025.800199_bib0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3393\/ac.2021.00633.0090","article-title":"Can pretreatment platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios predict long-term oncologic outcomes after preoperative chemoradiation followed by surgery for locally advanced rectal cancer?","volume":"38","author":"An","year":"2022","journal-title":"Ann Coloproctol."},{"issue":"3","key":"10.1016\/j.cireng.2025.800199_bib0150","article-title":"High neutrophil-lymphocyte ratio, platelet- lymphocyte ratio and low lymphocyte levels are correlated with worse pathological complete response rates","volume":"14","author":"Karakaya","year":"2022","journal-title":"Cereus."},{"issue":"25","key":"10.1016\/j.cireng.2025.800199_bib0155","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","article-title":"Randomized, controlled trials, observational studies, and the hierarchy of research designs","volume":"332","author":"Concato","year":"1995","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.cireng.2025.800199_bib0160","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis","volume":"48","author":"Peduzzi","year":"1995","journal-title":"J Clin Epidemiol"}],"container-title":["Cirug\u00eda Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173507725001723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173507725001723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:53:13Z","timestamp":1761670393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173507725001723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2173507725001723"],"URL":"https:\/\/doi.org\/10.1016\/j.cireng.2025.800199","relation":{},"ISSN":["2173-5077"],"issn-type":[{"value":"2173-5077","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomarkers could predict overall survival and disease-free survival after neoadjuvant therapy and surgery due to locally advanced rectal cancer","name":"articletitle","label":"Article Title"},{"value":"Cirug\u00eda Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cireng.2025.800199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of AEC.","name":"copyright","label":"Copyright"}],"article-number":"800199"}}